ASCO 2017: Key takeaways for lymphoma research
Kathryn Kolibaba, MD of US Oncology Research discusses the general takeaways from the oral sessions on lymphoma presented at the 2017 ASCO Annual Meeting in Chicago, IL. Author: obr Added: 06/21/2017 (Source: Oncology Tube)
Source: Oncology Tube - June 21, 2017 Category: Cancer & Oncology Source Type: podcasts

Results of the MAGNIFY study for high-risk indolent non-hodgkin lymphoma patients
Kathryn Kolibaba, MD of US Oncology Research discusses the MAGNIFY study and its impact on high-risk indolent NHL patients at the 2017 ASCO Annual Meeting in Chicago, IL. Author: obr Added: 06/21/2017 (Source: Oncology Tube)
Source: Oncology Tube - June 21, 2017 Category: Cancer & Oncology Source Type: podcasts

Results of BRIGHT study in front line indolent non-hodgkin lymphoma patients
Kathryn Kolibaba, MD of US Oncology Research gives an overview of the results from the BRIGHT study and its impact on treatment for indolent non-hodgkin lymphoma patients. This was recorded at the 201... Author: obr Added: 06/21/2017 (Source: Oncology Tube)
Source: Oncology Tube - June 21, 2017 Category: Cancer & Oncology Source Type: podcasts

Cutaneous T-Cell Lymphomas
Interview with Ellen J. Kim, M.D., discussing the JAMA Dermatology Patient Page entitled Cutaneous T-Cell Lymphomas (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - June 14, 2017 Category: General Medicine Authors: The JAMA Network Source Type: podcasts

JAMA Dermatology : Cutaneous T-Cell Lymphomas
Interview with Ellen J. Kim, M.D., discussing the JAMA Dermatology Patient Page entitled Cutaneous T-Cell Lymphomas (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - June 14, 2017 Category: General Medicine Authors: The JAMA Network Source Type: podcasts

Seattle Cancer Care Alliance: Promise for CAR-T Cell Therapy in ALL and Lymphoma
Nancy E. Davidson, MD of Seattle Cancer Care Alliance discusses the promising data coming out of SCCA for acute lymphoblastic leukemia (ALL) and lymphoma at the 2017 ASCO Annual Meeting in Chicago, IL... Author: ASCO2017 Added: 06/07/2017 (Source: Oncology Tube)
Source: Oncology Tube - June 7, 2017 Category: Cancer & Oncology Source Type: podcasts

Copanlisib in Patients with Relapsed or Refractory Follicular Lymphoma and DLBCL
Mark Rutstein, Vice President of Oncology Development of Bayer gives an overview of two poster presentations that focus on the use of Copanlisib for relapsed or refractory follicular lymphoma and rela... Author: ASCO2017 Added: 06/02/2017 (Source: Oncology Tube)
Source: Oncology Tube - June 2, 2017 Category: Cancer & Oncology Source Type: podcasts

Key Insights in Lymphoma
In this activity, meeting co-chair Dr. John P. Leonard provides the key take-home messages from the leukemia, myeloid disorders, and benign hematology sessions at the 2017 Great Debates & Updates ... Author: imedex Added: 04/25/2017 (Source: Oncology Tube)
Source: Oncology Tube - April 25, 2017 Category: Cancer & Oncology Source Type: podcasts

Anas Younes, MD - Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics
Making the Most of New Options in Hodgkin Lymphoma: Autologous Transplant in the Era of Novel Therapeutics (Source: PeerView Press CME/CE International Audio Podcast - Internal Medicine)
Source: PeerView Press CME/CE International Audio Podcast - Internal Medicine - April 21, 2017 Category: Internal Medicine Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts

Treatment Trends for Lymphoma in 2017
Martin Dreyling, MD of University of Munich Hospital in Grosshadern discusses the treatment trends for lymphoma in 2017, which include targeted therapy, chemotherapy, and combination therapy. This was... Author: aacr2017 Added: 04/19/2017 (Source: Oncology Tube)
Source: Oncology Tube - April 19, 2017 Category: Cancer & Oncology Source Type: podcasts

CHRONOS-1: Copanlisib in Patients With B-Cell Lymphoma
Martin Dreyling, MD of University of Munich Hospital in Grosshadern gives an overview of his presentation, CHRONOS-1, which shows the use of copanlisib in B-Cell Lymphoma patients. This was recorded a... Author: aacr2017 Added: 04/19/2017 (Source: Oncology Tube)
Source: Oncology Tube - April 19, 2017 Category: Cancer & Oncology Source Type: podcasts

How Can LLS Resources and Communities Help You?
Joining Patient Power from the Leukemia & Lymphoma Society, Dr. Gwen Nichols and Dr. Larry Saltzman discuss the mission and services of LLS and how these services can impact patients in a positive way... Author: patientpower Added: 04/18/2017 (Source: Oncology Tube)
Source: Oncology Tube - April 18, 2017 Category: Cancer & Oncology Source Type: podcasts

Strategies to focus on quality of life in choosing lymphoma therapy
In this presentation from Lymphoma & Myeloma 2016, Dr. Kelly M. Trevino discusses strategies to focus on quality of life when choosing a lymphoma therapy.<br /><br />Click to Earn CME Credit: <a target='_blank' href='http://bit.ly/2m'>http://bit.ly/2m...</a>... Author: imedex Added: 04/11/2017 (Source: Oncology Tube)
Source: Oncology Tube - April 11, 2017 Category: Cancer & Oncology Source Type: podcasts

Debate: 60 y/o Follicular lymphoma patient relapsing less than 2 years after upfront R-CHOP - Novel agents
In this presentation from Lymphoma & Myeloma 2016, Dr. Jeremy S. Abramson argues for the use of novel agents for a 60 year patient with follicular lymphoma who has relapsed less than two years after r... Author: imedex Added: 04/11/2017 (Source: Oncology Tube)
Source: Oncology Tube - April 11, 2017 Category: Cancer & Oncology Source Type: podcasts

Debate: 60 y/o Follicular lymphoma patient relapsing less than 2 years after upfront R-CHOP - SCT
In this presentation from Lymphoma & Myeloma 2016, Dr. David G. Maloney argues for stem cell transplant for a 60 year patient with follicular lymphoma who has relapsed less than two years after receiv... Author: imedex Added: 04/11/2017 (Source: Oncology Tube)
Source: Oncology Tube - April 11, 2017 Category: Cancer & Oncology Source Type: podcasts